$16.95 $0.14 per serving
Product analysis
Bromelain 500 mg supplies a protein-digesting enzyme at a favorable serving cost.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
Bromelain has a named pineapple source, but its quality remains uncertain. The source name does not settle the preparation’s enzyme activity.
Ingredient Transparency100
The bromelain amount and source are stated. Those details make the labelled contents easier to compare.
Value For Money100
The declared bromelain amount offers strong value. The favorable cost does not settle whether preparations have comparable enzyme activity.
Customer Satisfaction77
Customer ratings are very positive across a few hundred buyers. They describe satisfaction without establishing pain or digestive symptom relief.
Product Focus60
Bromelain has a protein-digesting role and limited pain-related findings in specific circumstances. Consistent everyday digestive relief or broad inflammation benefits remain uncertain.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $0.14
- Customer rating
- 4.7 · 467 ratings
Goals
Impact
Moderate effect
Bromelain · 500 mg
Bromelain at 500 mg is a protein-digesting enzyme. That activity gives it a digestive role, but evidence for consistent relief of everyday digestive symptoms from isolated bromelain remains limited.
How this product is rated for Gut Health
Ingredient fit97
The saved ingredient and amount findings center on digestive enzyme activity.
Goal fit
The saved findings connect the eligible ingredients mainly to digestive enzyme activity.
Dose adequacy
The eligible amount reaches the saved comparison target.
Pathways60
Support is concentrated on digestive enzyme activity, with limited breadth.
Depth
The strongest saved connection is to digestive enzyme activity.
Breadth
One digestive area reaches the saved coverage threshold; the contribution remains narrow.
Evidence58
Bromelain leads the saved findings, with preparation and population qualifications relevant to interpreting benefit.
Evidence strength
Bromelain leads the saved evidence assessment; the supplied reference qualifications limit how confidently this predicts everyday digestive benefit.
Studied preparation
The saved assessment accepts the eligible preparations as matching its evidence comparison.
Formulation logic100
The saved assessment identifies no conflicts or missing required partners.
Partner coverage
The eligible ingredients can contribute alone or have their required partners.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
All eligible ingredients meet the saved minimum amount criterion.
Impact
Moderate effect
Bromelain may help with pain in some specific circumstances, but a broad anti-inflammatory benefit is unclear. Pain relief around dental surgery does not imply reliable swelling reduction or relief from ongoing joint symptoms. Its enzyme activity and preparation matter, so a weight in milligrams alone cannot predict the same effect.
How this product is rated for Inflammation
Ingredient fit97
Bromelain provides the main connection to inflammation among the declared ingredients.
Goal fit
Bromelain provides the main connection to inflammation among the declared ingredients.
Dose adequacy
Bromelain 500 mg per selected serving; these amounts are comparisons, not guarantees of symptom relief.
Pathways18
The main connection concerns inflammation-related enzyme activity; this does not predict how much symptoms will change.
Depth
The main connection concerns inflammation-related enzyme activity; this does not predict how much symptoms will change.
Breadth
The connection is concentrated in inflammation-related enzyme activity, rather than a broad range of inflammatory processes.
Evidence62
Bromelain has limited, situation-specific relevance to pain; broader inflammation relief remains uncertain.
Evidence strength
Bromelain has limited, situation-specific relevance to pain; broader inflammation relief remains uncertain.
Studied preparation
The declared preparation matches the relevant ingredient context, without guaranteeing the same effect for everyone.
Formulation logic100
The relevant ingredients can act without a required partner, and no particular conflict is identified.
Partner coverage
The relevant ingredients do not require an additional partner for their described roles.
Conflicts
No particular ingredient conflict is identified for this goal.
Effective doses
Bromelain 500 mg per selected serving; these amounts are comparisons, not guarantees of symptom relief.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Bromelain (Pineapple) | 500 mg |
Bromelain (Pineapple) · 500 mg OverallScore95
Each serving provides 500 mg of bromelain, with a declared activity concentration of 2,400 GDU per gram. The whole-product price works out to about $0.14 per 500 mg of declared bromelain.
How this ingredient is rated
Composition and Label Disclosure100
The saved facts give an activity concentration of 2,400 GDU per gram, a figure that can be compared with other GDU-per-gram declarations.
Enzyme Activity Disclosure
Bromelain activity is stated in GDU, with 2,400 GDU per gram recorded.
Declared GDU per Gram
The declared activity concentration is 2,400 GDU per gram.
Composition and Label Disclosure87
The serving contains 500 mg of bromelain from pineapple.
Declared Bromelain Mass
The declared bromelain amount is 500 mg per serving.
Botanical Source Disclosure
Pineapple is identified as the source; the plant part is not specified in the saved facts.
Commercial Price and Usability100
Based on the whole-product price, the equivalent cost is about $0.14 per 500 mg of declared bromelain, a low cost in this comparison.
Cost per 500 mg Declared Bromelain
The whole-product price corresponds to about $0.14 per 500 mg of declared bromelain.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- The role of enzyme supplementation in digestive disorders.
- Effects of bromelain supplementation on disease activity and quality of life in patients with ulcerative colitis: a randomized, triple-blind, placebo-controlled study.
- Therapeutic efficacy of bromelain in impacted third molar surgery: a randomized controlled clinical study.
- Efficacy of proteolytic enzyme bromelain on health outcomes after third molar surgery. Systematic review and meta-analysis of randomized clinical trials.
- Placebo-controlled randomized clinical trial on the immunomodulating activities of low- and high-dose bromelain after oral administration - new evidence on the antiinflammatory mode of action of bromelain.
- An Evaluation of the Effects of Pineapple-Extract and Bromelain-Based Treatment after Mandibular Third Molar Surgery: A Randomized Three-Arm Clinical Study.
- Therapeutic uses of pineapple-extracted bromelain in surgical care - A review.